Patent search cpc:"Y10S514/951" Page 1

1.

发明专利
Agricultural chemical composition as well as the production method and the method of application that 有权

公开(公告)号：JP5059255B2

公开(公告)日：2012-10-24

申请号：JP2000353887

申请日：2000-11-21

Applicant: クミアイ化学工業株式会社

Inventor： 進加藤 , 茂樹藤田 , 透高柳

IPC: A01N25/00 , A01N25/08 , A01N25/10 , A01N25/14 , A01N25/26 , A01N25/34 , A01N37/34 , A01N43/78 , A01N47/12 , A01N47/30 , A01N47/36 , A01N47/38 , A01N57/14 , A01P13/00

CPC classification number: A01N25/26 , A01N25/14 , Y10S514/949 , Y10S514/95 , Y10S514/951

2.

发明专利
Calcium phosphate cement and method for using the same 审中-公开
Title translation: 磷酸钙水泥及其使用方法

公开(公告)号：JP2012192212A

公开(公告)日：2012-10-11

申请号：JP2012150927

申请日：2012-07-04

Applicant: Skeletal Kinetics Llc , スケルタルキネティクスエルエルシー

Inventor： CONSTANTZ BRENT R , DELANEY DAVID , YETKINLER DURAN

IPC: A61L27/00 , A61F2/28 , A61K6/00

CPC classification number: A61L27/12 , Y10S514/951 , Y10S514/955

Abstract: PROBLEM TO BE SOLVED: To provide methods and compositions for producing flowable compositions, e.g., pastes, which set into calcium phosphate products, also provide the compositions themselves as well as kits for use in practicing the subject methods, the subject methods and compositions produced thereby finding use in a variety of applications, including the repair of hard tissue defects, e.g., bone defects.SOLUTION: In the subject methods, dry reactants that include a calcium source and a phosphate source are combined with a setting fluid to produce the flowable composition. A feature of the subject methods is that the dry reactants include a particulate calcium and/or phosphate reactant having a mean particle size of less than about 8 μm and narrow size distribution.

Abstract translation: 要解决的问题：为了提供用于生产可流动组合物的方法和组合物，例如，设置为磷酸钙产品的糊剂，还提供组合物本身以及用于实践本发明方法的试剂盒，本发明的方法和由此产生的组合物可用于各种应用，包括修复硬组织缺陷，例如骨缺损。解决方案：在本发明的方法中，包括钙源和磷酸盐源的干燥反应物与凝固流体结合以产生可流动组合物。本发明方法的特征在于干燥的反应物包括平均粒度小于约8μm并且尺寸分布窄的粒状钙和/或磷酸盐反应物。版权所有（C）2013，JPO＆INPIT

3.

发明专利
Calcium phosphate cement which is prepared from silicate solution 有权

公开(公告)号：JP4996030B2

公开(公告)日：2012-08-08

申请号：JP2001579712

申请日：2001-04-27

Applicant: エスケーリサーチアンドディベロップメント, エルエルシー

Inventor： ブレントアール．コンスタンツ，

IPC: A61L27/00 , C04B12/02 , A61K6/06 , A61L24/00 , A61L24/02 , A61L27/12 , C04B14/36 , C04B24/00 , C04B28/34

CPC classification number: A61L24/02 , A61K6/0612 , A61K6/0643 , A61K6/097 , A61L27/12 , Y10S514/951 , Y10S514/953 , A61K6/087 , C08L89/00

4.

发明专利
The method and thereby the resulting product for the preparation of the filled oxide microcapsule by functional molecules 有权

公开(公告)号：JP4920132B2

公开(公告)日：2012-04-18

申请号：JP2000565089

申请日：1999-08-11

Applicant: ゾル−ゲルテクノロジーズエルティーディー.

Inventor： アヴニール、デイヴィッド , ガンズ、オリット , セリ−レヴィ、アロン , ソレーク、ヨーラム , マグダッシ、シュロモ , ラピドット、ノア , ロットマン、クラウディオ

IPC: A23L1/275 , B01J13/04 , A01N25/28 , A23L1/00 , A23L1/22 , A61J3/07 , A61K8/00 , A61K8/04 , A61K8/11 , A61K8/31 , A61K8/33 , A61K8/35 , A61K8/36 , A61K8/368 , A61K8/37 , A61K8/41 , A61K8/46 , A61K9/50 , A61K9/51 , A61K47/30 , A61Q17/04 , C09K3/00

CPC classification number: A61K8/042 , A23L27/72 , A61K8/11 , A61K8/35 , A61K8/37 , A61K9/5146 , A61K2800/412 , A61Q17/04 , Y10S514/937 , Y10S514/951 , Y10T428/2984

5.

发明专利
Injectable buprenorphine microparticle compositions and their use 有权

公开(公告)号：JP4913298B2

公开(公告)日：2012-04-11

申请号：JP2001519913

申请日：2000-08-25

Applicant: ブルックウッドファーマシューティカルズ,インコーポレイティド

Inventor： ケー．スタース，ジェイ , アール．タイス，トーマス , エム．ファーレル，テレサ , マークランド，ピーター

IPC: A61K9/14 , A61K31/485 , A61K9/16 , A61K9/50 , A61K47/10 , A61K47/14 , A61K47/32 , A61K47/34 , A61K47/38 , A61P25/30 , A61P25/32 , A61P25/36

CPC classification number: A61K9/0024 , A61K9/1647 , A61K9/5031 , A61K31/485 , Y10S514/811 , Y10S514/812 , Y10S514/951 , Y10S514/952

6.

发明专利
Cilostazol preparation 审中-公开
Title translation: CILOSTAZOL制剂

公开(公告)号：JP2011063611A

公开(公告)日：2011-03-31

申请号：JP2010258873

申请日：2010-11-19

Applicant: Otsuka Pharmaceut Co Ltd , 大塚製薬株式会社

Inventor： MUKAI MASASHI , TOMOHIRA YUZO , TODA MASABUMI , YAMADA KEIGO , OKA KEIICHI

IPC: A61K47/20 , A61K9/14 , A61K9/16 , A61K9/20 , A61K9/22 , A61K9/50 , A61K9/52 , A61K31/4709 , A61K47/34 , A61K47/38 , A61P1/04 , A61P9/10 , A61P9/12 , A61P43/00

CPC classification number: A61K9/145 , A61K9/146 , A61K9/1617 , A61K9/1652 , A61K9/2081 , A61K9/5042 , A61K9/5084 , A61K31/4709 , Y10S514/951 , Y10S514/952 , Y10S514/96 , Y10S514/961 , Y10S514/962 , Y10S514/963 , Y10S514/964

Abstract: PROBLEM TO BE SOLVED: To provide a preparation in which absorbability of cilostazol commercially available as an antithrombotic drug, a cerebral circulation improving drug and the like is improved, particularly at the lower portion of the gastrointestinal tract.
SOLUTION: A sustained release preparation of cilostazol having elution performance of cilostazol even at the lower part of the gastrointestinal tract is prepared by blending 1 pt.wt. of fine powder of cilostazol having an average particle size of not greater than 5 μm as an active ingredient with 0.005-50 pts.wt. of at least one surfactant selected from the group consisting of polyglycerol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene castor oil, sucrose fatty acid ester, and alkyl sulfate salt.
COPYRIGHT: (C)2011,JPO&INPIT

Abstract translation: 待解决的问题：提供一种其中作为抗血栓形成药物，大脑循环改善药物等可商购的西洛他唑的吸收性提高的制剂，特别是在胃肠道的下部。解决方案：即使在胃肠道下部也具有西洛他唑洗脱性能的西洛他唑缓释制剂是通过混合1重量％平均粒径不大于5μm的西洛他唑细粉末为0.005-50重量份的活性成分。的至少一种选自聚甘油脂肪酸酯，聚氧乙烯山梨糖醇酐脂肪酸酯，聚乙二醇脂肪酸酯，聚氧乙烯烷基醚，聚氧乙烯蓖麻油，蔗糖脂肪酸酯和烷基硫酸盐的表面活性剂。版权所有（C）2011，JPO＆INPIT